case_images: PMC11753241_01
case_images: Showcase of timeline with the changes in liver function, coagulation function, renal function, and vitamin B1. T-Bil, total bilirubin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; PTA, prothrombin activity; INR, international normalized ratio; BUN, blood urea nitrogen; Cr, creatinine; MRI, magnetic resonance imaging; i.v., intravenous.
case_images: fnut-11-1505974-g0001.jpg
case_images: PMC11753241_01_fnut-11-1505974-g0001.jpg
case_images: F1
case_images: The laboratory parameters for liver and renal function were progressively improved (Figure 1). His neurological symptoms improved, serum vitamin B1 level returned to 358.8 nmol/L (Figure 1), and the lesions in MRI were reversible 12 days post-vitamin B1 replacement therapy (Figure 2B).
case_images: Magnetic resonance imaging manifestation reveals (A) symmetric hyperintense signals on T2-weighted images in the bilateral inferior cerebellar peduncle, dorsal pons, and medial thalami as well as increased signal intensities on diffusion-weighted images (DWI) in bilateral thalami and hypothalamus. (B) The lesions were reversible after 12 days of intravenous vitamin B1 supplementation.
case_images: fnut-11-1505974-g0002.jpg
case_images: PMC11753241_01_fnut-11-1505974-g0002.jpg
case_images: F2
case_images: Cerebral magnetic resonance imaging (MRI) showed symmetric hyperintense signals on T2-weighted images in the bilateral inferior cerebellar peduncle, dorsal pons, and medial thalami as well as increased signal intensities on diffusion-weighted images within bilateral thalami and hypothalamus (Figure 2A). His neurological symptoms improved, serum vitamin B1 level returned to 358.8 nmol/L (Figure 1), and the lesions in MRI were reversible 12 days post-vitamin B1 replacement therapy (Figure 2B).